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Background: National malaria control programmes and their partners must document progress associated with
investments in malaria control. While documentation has been achieved through population-based surveys for
most interventions, measuring changes in malaria case management has been challenging because the increasing
use of diagnostic tests reduces the denominator of febrile children who should receive anti-malarial treatment.
Thus the widely used indicator, “proportion of children under five with fever in the last two weeks who received
anti-malarial treatment according to national policy within 24 hours from onset of fever” is no longer relevant.
Methods: An alternative sequence of indicators using a systems effectiveness approach was examined using data
from nationally representative surveys in Zambia: the 2012 population-based Malaria Indictor Survey (MIS) and the
2011 Health Facility Survey (HFS). The MIS measured fever treatment-seeking behaviour among 972 children under
five years (CU5) and 1,848 people age five years and above. The HFS assessed management of 435 CU5 and 429
people age five and above with fever/history of fever seeking care at 149 health facilities. Consultation observation
and exit interviews measured use of diagnostic tests, artemisinin combination therapy (ACT) prescription, and
patient comprehension of prescribed regimens.
Results: Systems effectiveness for malaria case management among CU5 was estimated as follows: [100% ACT
efficacy] x [55% fever treatment-seeking from an appropriate provider (MIS)] x [71% malaria blood testing (HFS)] x
[86% ACT prescription for positive cases (HFS)] x [73% patient comprehension of prescribed ACT drug regimens
(HFS)] = 25%. Systems effectiveness for malaria case management among people age five and above was estimated
at 15%.
Conclusions: Tracking progress in malaria case management coverage can no longer rely solely on population-
based surveys; the way forward likely entails household surveys to track trends in fever treatment-seeking
behaviour, and facility/provider data to track appropriate management of febrile patients. Applying health facility
and population-based data to the systems effectiveness framework provides a cogent and feasible approach to
documenting malaria case management coverage and identifying gaps to direct program action. In Zambia, this
approach identified treatment-seeking behaviour as the largest contributor to reduction in systems effectiveness for
malaria case management.
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Malaria has been a pervasive scourge across the cen-
turies, particularly in Africa, however tremendous ad-
vances in malaria control have been achieved in recent
years [1,2]. The improvements have been most notably
documented in the coverage of malaria prevention in-
terventions and have led to marked declines in malaria-
related child mortality. Despite this progress, malaria
remains a leading cause of death among children under
five [3], and a leading contributor to the global burden of
disease, particularly in sub-Saharan African [4]. The esti-
mated number of malaria cases in Africa in 2010 was 174
million [1]. Families, communities and health systems face
an ongoing burden of managing malaria infections. The
recently introduced highly efficacious artemisinin combin-
ation therapy (ACT) is now the first-line treatment in
most countries where Plasmodium falciparum is endemic
[1]. More recently, quality controlled rapid diagnostic tests
(RDTs) have proven valuable in confirming infections and
directing appropriate malaria treatment such that, along
with microscopy, diagnostic confirmation of malaria is
recommended worldwide [5].
Improvements in malaria control have been documented
using population-based surveys to chart changes in inter-
vention coverage [2,6]. These include the Demographic
and Health Survey (DHS), the Malaria Indicator Survey
(MIS), and the UNICEF Multiple Indicator Cluster Survey
(MICS). Tracking progress through these surveys has been
well characterized for malaria prevention coverage where
standard indicators have been tracked over time and pro-
vide a reliable picture of improvements [2]. However, for
case management, the primary indicator “proportion of
children under the age of five years with fever in the last
two weeks who received anti-malarial treatment according
to national policy within 24 hours from onset of fever” [6]
has several limitations. These include use of fever as a
proxy measure for malaria infection, and reliance on care-
giver reports for information on blood testing and medi-
cines used for treatment [6]. Further, in the face of recent
policy changes recommending confirmatory blood testing
prior to treatment, presumptive treatment of fever is no lon-
ger a valid indicator for appropriate case management [7].
Routine health management information systems (HMIS)
data capturing malaria blood testing, test results and
treatments administered are not subject to these limita-
tions. However, facility data fail to capture coverage
among the substantial proportion of the population
where treatment services are not available or among
those who do not seek care within the public health sys-
tem. Additionally, in many malaria-endemic countries,
HMIS are weak, data are incomplete, contain inaccur-
acies, and are unavailable in an actionable timeframe
[8]. Finally, HMIS data do not capture characteristics of
an individual patient’s interaction within the healthsystem. A facility-based survey designed to assess the ex-
tent and quality of service provision represents an ap-
proach that can provide complete and unbiased data in an
actionable timeframe. Linking facility survey data with
population-based data could provide a more complete pic-
ture of malaria case management coverage [8,9].
Zambia has made numerous improvements in malaria
case management in the last decade including adopting
the ACT artemether-lumefantrine (AL) as the first-line
treatment for malaria in 2002, and introducing RDTs in
health facilities in 2006 [10,11]. National guidelines for
diagnosis and treatment were modified in 2009–10 to
require parasitological confirmation by RDT or micros-
copy prior to malaria treatment wherever capacity is
available [12]. Scale-up of blood testing and AL treat-
ment was facilitated by substantial donor support. Be-
tween 2003 and 2010, external partners committed
nearly $200 million to malaria prevention and control in
Zambia [10]. Currently, the basic health care package
offered through the public health system in Zambia
includes blood testing and AL treatment. These and
other basic health services are provided free of charge
in health facilities located in rural and poor districts.
Zambians access care at three basic levels of public
health care: rural health posts and community outreach;
urban and rural health centres; and primary, secondary
and tertiary hospitals. Nearly all urban households are
located within 5 km of a health facility as compared with
50% of rural households. The relatively small private
for-profit sector operates in urban areas [13] and treat-
ment seeking in the private sector for suspected malaria
is relatively uncommon [14].
The MIS has been the primary tool for tracking recent
malaria control progress in Zambia; four rounds have
been implemented in 2006, 2008, 2010, and 2012. In
2011, a nationally representative Health Facility Survey
(HFS) was implemented. 2011 HFS and 2012 MIS data
and a systems effectiveness approach were used to docu-
ment malaria case management coverage in Zambia
following recent improvements. A systems effectiveness
framework evaluates coverage by examining the neces-
sary sequential components for effective health service
delivery [15]. This framework documents the extent to
which highly efficacious disease control tools effectively
reduce disease burden. Effectiveness is a function of
whether a disease control tool reaches the target group;
users and providers comply and perform correctly; and a
high level of coverage is sustained [16]. Effectiveness of
highly efficacious anti-malarial drug (i.e. ACT) is a func-
tion of: 1) treatment-seeking behaviour among febrile
individuals – seeking treatment from an appropriate pro-
vider; 2) malaria blood testing provided to patients with
fever to confirm malaria infection; 3) appropriate treat-
ment with ACT based on blood test results (provider
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treatment [17-20]. Consequently, the information required
to use this approach must come from multiple sources,
both from population data (using representative house-
hold surveys) and facility data (using representative health
facility surveys). Benchmarking systems effectiveness can
guide Zambia stakeholders towards action to improve
malaria case management.
Methods
2012 Malaria Indicator Survey (MIS)
Details on the Zambia MIS methods are described else-
where [21]. Briefly, the MIS is a national population-based
household survey designed to measure key indicators for
tracking malaria control progress. A random sample of
households stratified by urban and rural residence was
drawn using two-stage cluster sampling. Standard enumer-
ation areas were selected with probability-proportional-to-
size at the first stage and a random sample of 25 households
per cluster was selected at the second stage.
Within each sampled household, a standard question-
naire administered using a personal digital assistant
(PDA), collected basic information about the household
and each household member. The MIS Household and
Woman’s Questionnaires are modeled after the survey
instruments developed by the MEASURE DHS + pro-
gramme and adopted and recommended for use by the
Roll Back Malaria Monitoring and Evaluation Reference
Group Task Force on Household Surveys [22]. The stand-
ard household roster was expanded to include questions
about recent febrile illness, fever treatment-seeking behav-
iour, and anti-malarial treatment among all household
members. Each woman between the ages of 15 and 49
completed a standard woman’s questionnaire interview
that included questions about each of her children under
age five. These questions included information about
febrile illness occurring in the two weeks preceding the
survey, treatment-seeking behaviour, blood testing, and
anti-malarial treatment received for the fever. Where par-
ental consent was obtained, children were administered an
RDT and specimens were collected on a blood slide (BS)
for microscopy [22].
Fieldwork was completed between April and May,
2012; 3,800 households participated in the survey.
Within these households, information was collected in
the household questionnaire on 16,928 household mem-
bers, including 2,820 household members with recent
fever. Information about 2,620 children under five was
collected in the woman’s questionnaire from 2,301 bio-
logical mothers age 15–49, including 742 children with
recent fever.
All MIS and HFS research activities were reviewed by
the Research Ethics Committee of the University of
Zambia on behalf of the Ministry of Health, the PATHResearch Ethics Committee, and the US Centers for
Disease Control Institutional Review Board. Final au-
thority to conduct these research activities was obtained
from the Ministry of Health.
2011 Health Facility Survey (HFS)
Details on the Zambia HFS methods are described else-
where [23]. Briefly, the HFS was designed to provide
nationally representative information on facility-based mal-
aria case management. The study was modeled after the
World Health Organization Integrated Child Health Facility
Assessment [24] and applications in similar contexts [25].
The sampling frame consisted of a list of all health
facilities in Zambia compiled in 2009 by the Ministry of
Health (N = 1,843). Most health facilities in Zambia are
government-run (85%), although a few are run by private
for-profit (9%) or mission organizations (6%) [13]. As
such, the sample represents health facilities in Zambia,
with chance of including private and mission facilities
equivalent to their representation among all national
health facilities. The sample was drawn with explicit strati-
fication from lists of all facilities at each level of care:
health post (N = 266), urban health centre (N = 428), rural
health centre (N = 1,042), and hospital (N = 107). Within
each group, geographic stratification was done by ordering
facilities by location (province, district), and a random
sample of health facilities was selected using systematic
random sampling. Forty-two facilities were sampled from
each stratum for a total of 168 facilities. The overall facility
response rate was 89% (N = 149). The selected sample was
largely government (75%) and non-profit/mission facilities
(11%); 12% of the sampled facilities were private for-profit
and 3% were facilities for company employees (i.e., com-
mercial farm or mining companies).
Each facility was surveyed for one day during which a
sample of patients was selected. Inclusion criteria for the
study were as follows: patients visiting the outpatient
clinic for consultation with a health worker and present-
ing at the health facility for the current illness for the
first time. There were 1,464 patients identified as eligible
for the study. A participation rate of 95% (N = 1,394)
was achieved. Of these eligible patients, consultation
observation and exit re-assessment were performed for
1,290 patients who were reportedly seeking care for the ill-
ness for the first time. Of these patients, 872 had suspected
malaria (self-reported fever or a history of fever and/or
body temperature greater than or equal to 37°C), including
patients seeking care at hospitals (N = 213), urban health
centres (N = 221), rural health centres (N = 251), and
health posts (N = 187). One-half (51%) of the patients with
suspected malaria were under age five years.
Two patient-focused survey instruments were used: 1)
consultation observation form to capture case manage-
ment practices; and, 2) patient exit interview and re-
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completed first; laboratory tests and results for the pa-
tient were recorded on this form. After the patient fully
completed the consultation, the exit interview was con-
ducted to assess patient comprehension of the diagnosis
and prescribed drug regimens as well as patient recall
and assessment of health worker performance during
the consultation. Finally, a patient re-examination per-
formed by a trained health professional provided a gold
standard malaria diagnosis (clinical assessment con-
firmed by RDT).
Measurement and analysis
HFS indicators were created among the subsample of
patients with suspected malaria. Suspected malaria was
determined at an exit re-assessment and was defined as
presence of self-reported fever or a history of fever and/
or body temperature greater than or equal to 37°C. A
variable was created to indicate whether or not these pa-
tients received a blood test during consultation accord-
ing to the consultation observation form (interviewer
observation and/or information recorded from patient
records). Treatment with the national first-line ACT
(AL) was measured at exit interview by review of patient
medicines and/or prescriptions obtained during the facil-
ity visit. Variables concerning patient comprehension of
the drug regimen were created among those patients
who obtained AL at the health facility using questions
regarding the duration of treatment (number of days),
times per day the medicine was to be given, and dosage
(number of tablets). The respondent’s answers were con-
sidered with respect to the correct dosage determined
using patient age and weight information.
MIS indicators focus on treatment-seeking behaviour
and outcomes among people with fever in the two weeks
preceding the survey. This sample of recently febrile in-
dividuals included children under five years of age using
reports from women age 15 to 49 about their own bio-
logical children as well as all household members from
the household listing. While the 2012 MIS survey report
focuses on fever treatment-seeking behaviour for chil-
dren under five [21], this paper uses secondary data
analysis to produce estimates for people of all ages. Indi-
cators were calculated from the household listing for all
household members, except in the case of children
under five with information available from the mother’s
report, which serves as the standard source of fever
prevalence and treatment-seeking behaviour used by
major household survey groups. Variables were created
to indicate treatment seeking for recent fever at an ‘ap-
propriate provider’ – defined as any public or private
health facility or a community health worker (CHW).
Treatment-seeking and ACT treatment were calculated
among all febrile individuals, however information onblood testing (recall of a finger or heel stick as a stand-
ard proxy measure for a malaria blood test) was only
available for children under five recorded in the woman’s
questionnaire.
Tabulations and cross tabulations were performed using
Stata 12.1 (© StataCorp, College Station, TX, USA). Point
estimates and 95% confidence intervals (CI) are reported.
Data analyses took into account the survey design: MIS
stratification (urban/rural) and clustering of households
within standard enumeration areas, and HFS stratification
(level of care) and clustering of patients within health facil-
ities. All data were weighted to account for disproportion-
ate allocation of the sample to different strata.
An overall measure of systems effectiveness was calcu-
lated across key indicators on the pathway from ACT ef-
ficacy to effectiveness as follows: systems effectiveness =
[AL efficacy (documented 100% [26])] x [% people with
current or recent fever who reportedly sought treatment
from an appropriate provider (MIS)] x [% patients with
current or recent febrile illness seeking care at an appro-
priate provider who received a malaria blood test (HFS)]
x [% patients with a positive blood test who received AL
(HFS)] x [% patients prescribed AL who demonstrated
full comprehension of the treatment regimen (HFS,
proxy for adherence)] [16].
Results
2012 Malaria Indicator Survey (MIS)
The MIS captures self-reported fever management out-
comes among people with fever in the two weeks prior
to the household survey. More than half of children
under five years of age (63%) and people age five years
and above (58%) sought fever treatment outside of the
home. Treatment from an appropriate provider (CHW,
public health facility, or private health facility) was
sought among more than half (55%) of children under
five years and 44% of people age five years and above
(Figure 1). Among people seeking treatment from an ap-
propriate provider (N = 1,257), 71% reportedly visited a
public health centre; 15% visited a public hospital; 4%
visited a public health post; 1% visited a CHW; and 7%
visited a private facility. Seeking fever treatment from
other private outlets is reportedly uncommon in Zambia
(10% of children under five and 13% of people age five
and above) (Figure 1). Among people seeking treatment
in other private outlets (N = 333), 71% reportedly visited
a shop and 28% visited a pharmacy.
The MIS measured blood testing among children
under five recorded in the woman’s questionnaire.
Among children with recent fever, 31% reportedly re-
ceived a blood test for malaria. Blood testing varied ac-
cording to where children were taken for treatment.
Among children managed exclusively by an appropriate
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Figure 1 Percentage of people with recent fever who reportedly sought treatment outside of the home, across age. Source: MIS 2012
household roster and woman’s questionnaire.
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portedly had a blood test (Figure 2).
Figure 3 examines use of ACT relative to other anti-
malarials reportedly used for recent fever. Among those
reportedly treated with any anti-malarial, 86% of chil-
dren under five and 78% of people age five and above
received an ACT. ACT treatment was higher among
people exclusively managed by an appropriate provider
(86% of children under five, 81% of people age five and
above) as compared with people managed by pharmacies
or shops (72% of children under five, 46% of people age
five and above) (Figure 3).
Malaria RDTs were administered and BS specimens for
microcopy were collected from children under five who
were recorded in the woman’s questionnaire. Among re-
cently febrile children who did not seek treatment from an
appropriate provider, current infection was identified in
the 30% who were both BS and RDT positive. These re-
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Figure 2 Percentage of children under five with recent fever
who reportedly received a blood test, across provider type.
Source: MIS 2012 woman’s questionnaire. 1 CHW, public or private
facility. 2 Pharmacy, shop.febrile illness who are not taken to an appropriate provider
actually harbour malaria infection – an infection that may
persist untreated, contributing to transmission, ongoing
morbidity, and potentially severe illness and even death.
About half of recently febrile children who did not seek
treatment from an appropriate provider had no evidence
of malaria infection (44% BS and RDT negative), and an
additional 25% were BS negative and RDT positive – pos-
sibly indicating recent anti-malarial treatment with medi-
cations that were stored at home or acquired from
another source (Table 1).
Among children who were taken to an appropriate
provider for fever treatment, 16% remained BS and RDT
positive at the time of the survey, and an additional 33%
were BS negative and RDT positive (Table 1). The frac-
tion of children who reportedly received care from an
appropriate provider but nonetheless remained BS posi-
tive at the time of the survey suggests that these infec-
tions were not effectively managed.
Among children under five years who were BS and
RDT positive, fewer than half (44%) reportedly expe-
rienced fever in the two weeks preceding the survey.
Prevalence of recent fever among infected children
declines with age from 61% to 37% between ages 12 to
23 months to age 48 to 59 months (Table 2).
2011 Health Facility Survey (HFS)
The HFS documents observed fever management out-
comes among patients with suspected malaria (fever or
history of fever) seeking treatment at a health facility.
Among patients with suspected malaria exiting public
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Figure 3 Percentage of people with recent fever treated with an anti-malarial who received ACT treatment, across age and provider
type. Source: MIS 2012 household roster and woman’s questionnaire. 1 CHW, public or private facility. 2 Pharmacy, shop.
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blood test for malaria. Data trends show higher testing
rates among patients managed in hospitals and urban
health centres as compared with rural health centres and
health posts (Figure 4).Table 1 Malaria infection among recently febrile children, acr
Did not seek treatment from an appropriate provider1
All children 0-11 months 12-23 mont
N fever 443 62 95
% BS-, RDT- 44.1 70.3 44.3
(36.1-52.5) (57.8-80.3) (31.2-58.2)
% BS+, RDT+ 29.9 17.4 39.0
(24.1-36.6) (9.7-29.3) (26.3-53.3)
% BS-, RDT+ 24.8 9.4 16.8
(19.4-31.0) (3.4-23.4) (11.0-24.8)
% BS+, RDT- 1.2 2.9 0.0
(0.5-3.0) (0.7-11.1)
Sought treatment from an appropriate provider1
All children 0-11 months 12-23 mont
N fever 451 74 86
% BS-, RDT- 49.8 68.8 59.2
(41.9-57.7) (56.2-79.1) (43.9-72.9)
% BS+, RDT+ 16.2 6.1 13.1
(12.6-20.7) (2.9-12.3) (7.7-21.4)
% BS-, RDT+ 33.2 23.1 27.7
(27.1-40.0) (14.9-34.0) (17.9-40.3)
% BS+, RDT- 0.7 2.1 0.0
(0.3-2.0) (0.5-8.1)
Source: MIS 2012 household roster and woman’s questionnaire.
1 CHW, public or private facility.Among patients tested formalaria during the consultation,
230 (39%) tested positive and 378 (61%) tested negative.
Among patients who tested positive during consultation,
86% of children under five and 89% of people age five and
above were prescribed ACT. Low levels of ACT prescriptionoss treatment-seeking behaviour and age




















Table 2 Recent fever among infected children, across age
N BS and RDT+ % Recent fever (95% CI)
All children 512 43.7 (36.8-50.9)
Age
0-11 months 46 39.0 (25.2-54.8)
12-23 months 85 61.2 (47.6-73.2)
24-35 months 122 43.4 (33.9-53.3)
36-47 months 124 42.4 (31.7-53.8)
48-59 months 135 36.5 (26.5-47.8)
Source: MIS 2012 household roster and woman’s questionnaire.
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consultation: 11% of children under five and 12% of people
age five and above (Figure 5). Use of other anti-malarials
(quinine, sulphadoxine-pyrimethamine (SP)) to treat sus-
pected malaria cases was infrequently observed among all
patients including those who were not tested during consult-
ation (3%); patients with a negative blood test result (3%);
and patients with a positive blood test result (3%).
Patients exiting with a prescription for AL were asked to
explain the drug regimen, including dosage (number of
tablets based on age/weight), doses per day (two times),
and number of days to give the drug (three days). Complete
correct knowledge of the regimen was demonstrated by
73% of caregivers of children under five and 61% of care-
givers/patients age five and above (Figure 6).
Systems effectiveness for malaria case management
The overall systems effectiveness for malaria case man-
agement is 25% for children under five years and 15%
for people age five years and above (Figure 7). These re-
sults are influenced most heavily by losses at the first
step in the case management cascade – low rates of0%
Health post (N=86)
Rural health center (N=116)
Urban health center (N=117)
Hospital (N=110)
All patients age 5+ (N=429)
Health post (N=97)
Rural health center (N=134)
Urban health center (N=102)
Hospital (N=102)
























Figure 4 Percentage of patients with suspected malaria1 who receive
Source: HFS 2011. 1 Self-reported fever or a history of fever and/or body teseeking treatment from an appropriate provider. More
than half (56%) of people age five years and above and
45% of children under five years of age with suspected
malaria (i.e. current or recent fever) are lost at this stage.
Blood test results among children under five indicate
that the loss is considerably smaller (14%) when consid-
ering only those children who had positive RDT and BS
results (Figure 7).
Discussion
Documenting malaria case management progress in the
context of recent ACT and RDT scale-up has been a
challenge given limitations of the most commonly avail-
able data sources - population-based household surveys
(MIS, DHS) and HMIS data. The challenge to document
progress in Zambia was addressed by applying a systems
effectiveness approach using the available national
household survey data (2012 MIS), and the recently
available national health facility survey data (2011 HFS).
Assembling results from these surveys, overall systems
effectiveness was estimated at 25% for children under
five, and 15% for people age five and above. In other
words, malaria diagnosis and treatment services in
Zambia are effective in managing 25% and 15% of sus-
pected cases under age five and age five years and above,
respectively. Tracking the steps from efficacy to systems
effectiveness highlighted areas that require strengthening
to improve case management coverage.
The first step in the cascade from ACT efficacy to
systems effectiveness is seeking treatment from an ap-
propriate provider. In this context, appropriate providers
include public or private health facilities and CHWs.
These sources are the focus of national policies, guide-
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% Patients with suspected malaria1
Figure 5 Percentage of patients who were prescribed the first line ACT (AL) across blood test results, patient age, and level of care.
Source: HFS 2011. 1 Self-reported fever or a history of fever and/or body temperature greater than or equal to 37°C.
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according to the set of promoted providers in a given
country. Failure to seek treatment from an appropriate
provider represents the largest threat to systems effect-
iveness in Zambia; only about half of people with recent
fever reportedly sought care from an appropriate pro-
vider. This gap suggests a need for more information on
barriers and facilitating factors for fever treatment-
seeking behaviour in this context. The MIS is well suited
to estimating levels of and at least some of the factors
determining treatment-seeking behaviour for recent0% 2
Health post (N=28)
Rural health center (N=46)
Urban health center (N=33)
Hospital (N=41)
All patients age 5+ (N=148)
Health post (N=29)
Rural health center (N=60)
Urban health center (N=21)
Hospital (N=26)
























Figure 6 Percentage of patients prescribed AL who demonstrated ful
number of times per day), across patient age and level of care. Sourcefever. These include a measure of household socio-
economic status, child characteristics including age, and
mother’s education, malaria knowledge, and exposure to
malaria communications, and household distance to a
health facility or appropriate care provider. This infor-
mation can be used to improve intervention targeting.
To address gaps in treatment-seeking behaviour, MIS
and other population-based data on treatment-seeking
behaviour should be reviewed in the context of national
programme information on service availability. For ex-
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Figure 7 Systems effectiveness for malaria case management in Zambia. * Source: 2012 MIS, ** Source: 2011 HFS. 1 CHW, public or private
facility. 2 Systems effectiveness = [ACT efficacy] x [sought fever treatment from an appropriate provider] x [malaria blood testing] x [AL prescription for
positive cases] x [AL regimen comprehension]. The calculation for children under five is: [1.00] x [0.548] x [0.712] x [0.864] x [0.734] = 0.247, or 25%. The
calculation for people age five and above is: [1.00] x [0.436] x [0.638] x [0.89] x [0.605] = 0.15, or 15%.
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through extension of diagnosis and treatment to the
community level. CHWs are recruited, trained and su-
pervised to provide malaria-specific or integrated pack-
ages of community-based case management [27]. Results
from the 2012 MIS suggest that, at national level, fever
cases are not typically managed by these community
agents (only 2% of children under five with recent fever).
However, given that community case management pro-
gramme coverage is subnational, additional analyses
should evaluate CHW service utilization explicitly in
areas with current programme coverage. These analyses
would provide information on the extent to which the
strategy facilitates appropriate treatment-seeking behav-
iour. Assembling existing data on service availability and
utilization can facilitate targeted investment in scale-up to
improve national coverage. Where existing data cannot
adequately explain underutilization of accessible care
options, additional information about treatment-seeking
behaviour may be needed. Qualitative research, often
entailing use of rapid ethnographic methods, is commonly
employed to understand the complexities and variationsin illness identification and treatment-seeking behaviour.
Recent reviews suggest that such studies could be
strengthened through application of theory and longer-
term engagement through methods such as extended case
studies and ethnography [28-30].
The second systems effectiveness step is blood testing
for suspected malaria. Frequency of blood testing as
measured in the Zambia HFS was high; 71% of patients
under age five and 64% of patients age five years and
above received a blood test. The MIS also provides a
rough approximation of blood testing in this context
and suggests that 61% of children under five taken to an
appropriate provider were tested for malaria. Findings
from a recent Zambia study to validate standard MIS
questions also suggest that the MIS may underestimate
blood testing [9]. While both surveys show impressive
improvement in malaria testing coverage in Zambia
[31,32], gaps persist. Health facility assessments provide
an opportunity for measuring a number of factors that
may influence blood-testing practices; these include
facility factors (e g, availability of RDTs, microscopy, na-
tional guidelines, and job aids, level of care, staffing),
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isfaction, client case load), and patient factors (e g, age,
other symptoms).
The third essential step for systems effectiveness is
ACT treatment for people with confirmed malaria infec-
tion. Zambia HFS results indicate tremendous progress
in this area - most people who test positive for malaria
are prescribed ACT (86% for children under five and
89% for age five and above). The HFS is unique in its
ability to determine rates of ACT prescription based on
test results. Additionally, HFS results in Zambia indicate
that in most cases, ACT is dispensed rationally based on
test results; ACT was prescribed to just one in ten pa-
tients who tested negative for malaria. Tracking rational
use can help explain reductions in systems effectiveness
at this stage where over prescription may contribute not
only to inefficiencies, but to stock-outs that ultimately
prevent ACT prescription for positive cases. ACT use
based on test results is not well captured in household
surveys. The MIS can include questions about malaria
blood test results, however patients seeking care may
not be adequately and accurately informed about test re-
sults and/or may not accurately recall the result [9].
Routine collection of facility data through the HMIS
could capture information on testing and treatment.
However, in the Zambian context, the HMIS collects
aggregate reports on numbers of patients tested and treat-
ments dispensed, rather than individual patient data on
testing, diagnosis, and treatment. Efforts to strengthen the
reporting and linkages of data on stock management and
disease reporting could facilitate additional triangulation
of information for review on a routine basis.
With the wide recognition that the previous global in-
dicator based on presumptive anti-malarial treatment of
fever is no longer informative, a new indicator proposed
by the Roll Back Malaria Monitoring and Evaluation
Reference Group is “the proportion of people receiving
an ACT, among people with fever in the last two weeks
who received any anti-malarial drugs [7]”. Applying this
indicator in Zambia, most anti-malarial treatments re-
portedly received are ACT (86% for children under five
and 78% for age five and above), particularly where treat-
ment is acquired from an appropriate provider. In other
contexts, where the anti-malarial market is diverse both
in terms of market share and in types of anti-malarials
in circulation, this MIS indicator could provide informa-
tion on anti-malarial prescription among various pro-
vider types to supplement a more targeted facility survey
focused on tracking behaviour among certain providers.
Nonetheless, the MIS ACT indicator denominator is only
among those individuals who received any anti-malarial
and does not permit evaluation of those not receiving an
anti-malarial for whatever reason. The HFS can track ap-
propriate and rational ACT use, and can capture andexplore facility, provider, and patient factors associated
with prescription behaviour to inform intervention.
The final step in the systems effectiveness framework
is patient adherence to the drug regimen. Data on drug
adherence are often imperfect; the behaviour is difficult
to measure, self-report measures may be unreliable [33],
and a 2005 review noted that there is insufficient infor-
mation on adherence to anti-malarials [34]. In the ab-
sence of a direct measure of adherence to AL in Zambia,
a proxy measure was used - comprehension of the drug
regimen at exit from a health facility. While the relation-
ship between comprehension and adherence may not be
exact, a recent study of AL adherence in Kenya iden-
tified correct knowledge of the drug regimen as the
strongest predictor of adherence [35]. To fully estimate
effective case management intervention coverage, and to
monitor behaviours that can contribute to anti-malarial
drug resistance, additional study designs and instru-
ments are needed.
The systems effectiveness approach to assemble
household and facility data appears to provide the most
complete picture of malaria case management to date.
However, one of the limitations in linking these data
sources through this approach is in treating self-
reported fever as a proxy and denominator for sus-
pected malaria in the overall calculation of systems
effectiveness. The approach assumes that febrile indi-
viduals with malaria infection are no more or less likely
to seek treatment than febrile individuals who do not
harbour malaria infection. Following this logic, all fevers
must be managed by an appropriate provider in order to
reach all malaria cases. In reality, the malaria-attributable
fraction of febrile cases varies across seasons and contexts,
and declines with scale-up of control interventions [36].
In treating all reported fevers the same, the approach
underestimates the overall systems effectiveness for
managing true symptomatic parasitaemic cases. Indica-
tion of this under-estimation is apparent in examining
blood test results for children with fever who were not
taken to an appropriate provider; nearly half were both
BS and RDT negative. It is also important to note that
this framework is limited in its application to manage-
ment of symptomatic malaria infections. Focusing on
symptomatic cases to reduce severe disease and death is
appropriate in the context of malaria control in high
transmission settings. However, asymptomatic (afebrile)
infections contribute to ongoing transmission as well as
disease burden [37,38]. Analysis of MIS blood test re-
sults among children under five indicates that fewer
than half (44%) of children that were both BS and RDT
positive reportedly experienced recent fever. Clearing
malaria infections – both symptomatic and asymptom-
atic – will require different intervention strategies and
different metrics to document progress [39-41].
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instruments and methods, and data were collected among
a nationally representative sample. Despite these strengths,
each data source has limitations. First, while each study
provided reasonably precise estimates for key indicators,
comparisons across age groups and levels of care resulted
in loss of precision (i e, wide confidence intervals) due to
smaller sample sizes among these subgroups. Sample size
calculations for facility surveys are challenging given a
number of factors that influence the ultimate numbers of
study participants among each subgroup of interest, in-
cluding cases of suspected malaria, confirmed cases, and
treated cases. Measurement bias is another limitation in
both studies. Household surveys estimate aspects of cover-
age using respondent reports, which are subject to recall
bias. This bias is minimized in the MIS and other standard
surveys by administering questions regarding fever that
occurred recently - in the two weeks prior to the survey.
Initial studies aimed at validating respondent recall and re-
sponse suggest need for further research [9]. Consultation
observation and patient exit interviews were used in the
HFS. These methods are subject to the Hawthorn effect –
a bias that may arise due to study participant awareness of
being under observation; health workers may perform bet-
ter than usual given presence of study teams [42,43]. This
study facilitated triangulation of HFS results with MIS
findings to some extent (e g, regarding blood testing for
suspected malaria), thereby strengthening conclusions.
Neither data source provided direct measure of adherence
to AL – a major limitation to completing the systems
effectiveness framework. Further research is needed on
this behaviour in Zambia. Data to estimate systems effect-
iveness were collected through two discrete surveys, one
in 2011 (HFS) and one in 2012 (MIS). Temporal dif-
ferences are important to consider when assembling data
from different surveys because in many contexts, case
management interventions and coverage are rapidly evolv-
ing. While data from Zambia used in this analysis were
not collected simultaneously, the systems they were evalu-
ating were relatively stable over the time period encom-
passing both surveys, facilitating meaningful combination
of survey results. While the systems effectiveness frame-
work highlighted the extent to which gaps exist in the
pathway from efficacy to effectiveness, there remains a
need to delve deeper into each step to inform interven-
tions. Specific strategies for improving treatment-seeking
behaviour, as well as blood testing, rational AL use, and
patient adherence, can be developed based on further
studies of factors associated with these outcomes.
Applications of the systems effectiveness framework to
benchmark progress in other country contexts may
require additional data beyond what was applied in this
study. Investments to improve malaria case management
in Zambia have focused primarily on public healthfacilities and CHWs, augmented by a relatively small
contingent of private health facilities. Among this set of
appropriate providers, 2012 MIS data indicate that
health facilities were commonly accessed while CHWs
were an infrequent source of care for fever management
at national level. Thus fever management components of
the systems effectiveness framework were completed
using information from health facilities. In comparison,
health systems for case management in other malaria
endemic countries are more diverse; appropriate pro-
viders who are authorized, trained, and promoted to
manage malaria may include private sector providers in-
cluding pharmacies, drug shops, and mobile vendors
[44,45]. Although the health system for malaria case
management is unique in each country, benchmarking
progress using a systems effectiveness framework seems
applicable across contexts. Where the system is com-
prised of multiple actors operating in community, pub-
lic, and private spheres, assembling a picture of systems
effectiveness will require information first on the extent
to which each component of the system is accessed for
care; and second, information on case management
(blood testing and drug prescription) within each of the
various system components. Ultimately, the utility of the
systems effectiveness framework lies in the simplicity of
assembling and interpreting data from multiple sources.
This utility should be tested in the context of diverse
health systems for malaria case management.
Conclusion
Health facility and population-based household survey
data (HFS and MIS) applied to the systems effectiveness
framework provides a cogent and feasible approach to
documenting malaria case management coverage. In
Zambia, these results indicate that the largest threat to
systems effectiveness is appropriate treatment-seeking
behaviour – which can encompass both access to ap-
propriate case management service providers as well as
service utilization. Although room for improvement re-
mains, study results demonstrate high facility coverage
of blood testing for patients with symptoms of malaria
and high rates of rational ACT use. Further analysis of
the MIS and HFS can identify specific factors associated
with treatment-seeking behaviour, blood testing, and ra-
tional AL use and can inform interventions to improve
malaria diagnosis and treatment. Until now, tracking
progress in malaria case management coverage has re-
lied heavily on population-based surveys. The way for-
ward likely entails household surveys to track trends in
treatment-seeking behaviour, and facility/provider data
(survey, routine, or supervisory data) to track appropri-
ate management of suspected malaria cases. Finally, as
programmes embark on the road to malaria elimination,
blood-testing components of household surveys can
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atic (febrile) and recent fever is an indicator of infection.
This information can shape appropriate interventions to
target both symptomatic and asymptomatic infections.
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